肝硬化腹水的肝，机械阻塞或心脏衰竭。
Ascites due to cirrhosis of the liver, mechanical obstruction or cardiac failure.
介绍许鑫梅教授治疗肝硬化腹水的经验。
Prof. Xu s experience on the treatment of ascites dueu to cirrhosis was presented.
应努力预防肝硬化腹水患者发生肾衰竭。
Efforts should be made to prevent renal failure in cirrhotic patients with ascites.
目的对肝硬化腹水临床的治疗方法进行分析。
Objective Clinical treatment of liver cirrhosis were analyzed.
目的：观察中药药膳治疗肝硬化腹水的临床效果。
Objective:To observe the clinical effect of medicated diet of TCM on cirrhosis ascites.
目的：探讨中西药联合治疗肝硬化腹水的临床疗效。
Objective Purpose: in the study western medicine consociation treatment hepatocirrhosis ascites clinical curative effect.
目的观察消胀利水合剂治疗肝硬化腹水的临床效果。
Objective to observe clinical effects of ascites due to cirrhosis treated with Xiao Zhang li Shui mixture.
目的探讨利尿剂治疗肝硬化腹水疗效的部分影响因素。
Aim to investigate the clinical factors influencing the therapeutic response to diuretic treatment of ascites in liver cirrhosis.
目的观察腹水浓缩静脉回输治疗难治性肝硬化腹水的疗效。
Objective to observe the therapeutic effects of ascitic concentration and venous re-transfusion on refractory ascites due to cirrhosis.
目的：探讨复方中药制剂治疗顽固性肝硬化腹水的临床疗效。
AIMS: to study clinical efficacy of Chinese herbs in treating refractory ascites in cirrhotic patients.
前言：介绍李德新教授“肝硬化腹水从脾论治”的学术观点。
This paper introduces professor li Dexin s academic viewpoints of treating ascites due to live cirrhosis through spleen.
目的探讨腹水超滤浓缩腹腔回输治疗顽固性肝硬化腹水的效果。
Objective To explore the therapeutic effect of ascites superfilter concentration and reinfusion method on hepatic cirrhosis patients with refractory ascites.
前言：目的：探讨并整理名老中医韩哲仙治疗肝硬化腹水的经验。
Objective: to investigate and sort out the experience of an aged TCM. doctor of Hanzhexian in treating ascites due to liver cirrhosis.
中医治疗鼓胀临床疗效显著，是现代治疗肝硬化腹水的重要方法之一。
TCM bulging significant clinical effect, the modern treatment of ascites due to cirrhosis of the important methods.
大多数肝硬化腹水的患者凝血酶原时间延长并有一定程度的血小板减少。
The majority of patients with ascites due to cirrhosis have prolongation of the prothrombin time and some degree of thrombocytopenia.
结论肝功能分级和血肌酐水平是影响肝硬化腹水利尿剂疗效的重要因素。
Conculsion Childs-Pugh score and plasma creatinine level were the risk factors influencing the therapeutic response to diuretic treatment of ascites in liver cirrhosis.
新药(如V 2受拮抗剂和血管收缩剂等)对肝硬化腹水的治疗可能带来希望。
New medicines such as vasoconstrictors and V2-receptors of vasopressin maybe beneficial in patients with ascites in liver cirrhosis.
今举肝硬化腹水、门静脉高压症、非酒精性脂肪肝、黄疸四则验案详细说明之。
Such four cases as ascites due to cirrhosis, portal hypertension; non-alcoholic fatty liver and jaundice were presented for a detailed explanation.
结论前列地尔对肝硬化腹水患者脏器功能有明显改善作用，并且长期疗效显著。
ConclusionAlprostadil has a role in the treatment of liver cirrhosis with jaundice by significantly improving the long term effect organ function.
结论：应用F6型透析器进行肝硬化自体腹水浓缩透析回输治疗肝硬化腹水效果良好。
Conclusion: it is effective on the liver cirrhosis self-ascites concentrated and reinfusion by using F6 dialyzer.
目的：探讨肝硬化腹水合并自发性细菌性腹膜炎（SBP）菌株种类、临床特点和预后。
Objective: Bacterium type, clinic character and prognosis of hepatocirrhosis ascites with spontaneous bacillary peritonitis (SBP) were discussed in this study.
目的：观察苍牛防己汤治疗肝硬化腹水的临床疗效，探讨治疗肝硬化腹水的有效方案。
Objective: to observe the effect of Cang Niu Fang Ji Tang in treating cirrhosis ascites, and to make an effective approach to treat cirrhosis ascites.
我们评估了肝硬化腹水患者不同类型功能性肾衰竭的发病率与预后并调查了其预后指标。
We assessed the incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites and investigated prognostic factors for these disorders.
方法通过19例肝硬化腹水患者临床资料进行回顾性分析，对肝硬化腹水的治疗方法前瞻性探究。
Methods 19 patients with liver cirrhosis were retrospectively analyzed clinical data on the treatment of ascites due to cirrhosis forward-looking inquiry.
目的研究肝硬化腹水合并结核性腹膜炎首诊误诊为原发性细菌性腹膜炎及原发性肝癌性腹水的原因。
Objective to study the reasons that cirrhotic ascites complicated with tuberculous peritonitis was misdiagnosed as primary bacterial peritonitis and carcinomatous ascites at the 1st clinic visit.
但肝硬化腹水组肾动脉阻力指数（RI）和搏动指数（PI）均显著高于其余两组（P<0.01）。
But resistive index (RI) and pulsatile index (PI) were markedly higher in cirrhotic patients with ascites than that in cirrhotic patients without ascites and that in the control group (P<0.01).
结果肝硬化腹水病情复杂且变化快并且治疗难度大，采用综合的治疗方法，因人施治多能达到较好疗效。
Results cirrhosis disease is complex and difficult to change quickly and treatment, integrated treatment, the person giving of treatment to achieve better and more effective.
方法对85例肝硬化腹水患者在综合治疗的基础上，对其进行基础护理、心理护理、基础护理、饮食护理等综合护理。
Methods 85 cases of combined therapy in patients with liver cirrhosis on the basis of its primary care, mental care, basic care, diet care, comprehensive care.
方法：对54例肝硬化腹水患者在以健脾利水，和肝益肾及化瘀软坚的治疗基础上加用护肝、利尿、白蛋白等综合治疗。
Methods:54 cases of cirrhotic ascites were treated base upon the therapeutic principle of Chinese medicine, include to protect liver function, diuresis, albumin injection etc.
方法：对54例肝硬化腹水患者在以健脾利水，和肝益肾及化瘀软坚的治疗基础上加用护肝、利尿、白蛋白等综合治疗。
Methods:54 cases of cirrhotic ascites were treated base upon the therapeutic principle of Chinese medicine, include to protect liver function, diuresis, albumin injection etc.
应用推荐